Literature DB >> 19520697

Macular hole formation after macular haemorrhage associated with rupture of retinal arterial macroaneurysm.

N Sagara1, T Kawaji, Y Koshiyama, Y Inomata, M Fukushima, H Tanihara.   

Abstract

AIM: To investigate the frequency and risk factors of macular hole (MH) formation after rupture of a retinal arterial macroaneurysm.
METHODS: Fifty-six eyes from 56 patients with rupture of a retinal arterial macroaneurysm with or without an MH (MH and non-MH groups, respectively) were reviewed. Frequency and risk factors related to MH formation were assessed, with risk factors including age; sex; distance from the macroaneurysm to the fovea; incidence of haemorrhages involving the macula such as preretinal, subinternal limiting membrane (sub-ILM), subretinal and vitreous; and vitreous surgery. MH formation in these patients was recorded and analysed.
RESULTS: Of the 56 eyes reviewed, seven (12.5%) had an MH after rupture of the retinal arterial macroaneurysm. The incidence of subretinal and sub-ILM haemorrhages involving the macula was significantly greater in the MH group than in the non-MH group (p = 0.037 and 0.045, respectively).
CONCLUSION: These results suggest that the presence of subretinal and sub-ILM haemorrhages after rupture of a retinal arterial macroaneurysm may contribute to formation of an MH.

Entities:  

Mesh:

Year:  2009        PMID: 19520697     DOI: 10.1136/bjo.2008.149195

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Laser therapy versus observation for symptomatic retinal artery macroaneurysms.

Authors:  Jacob C Meyer; Baseer U Ahmad; Kevin J Blinder; Gaurav K Shah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-13       Impact factor: 3.117

2.  Macular Hole Secondary to Polypoidal Choroidal Vasculopathy.

Authors:  Prabu Baskaran; Utsab Pan
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jul-Sep

3.  Management of a Macular Hole Following Retinal Arterial Macroaneurysm Rupture.

Authors:  Xhevat Lumi; Fran Drnovšek
Journal:  Am J Case Rep       Date:  2020-05-09

4.  Vitrectomy With Peeling the Internal Limiting Membrane for the Treatment of Macular Hole Following Ruptured Retinal Arterial Macroaneurysm: A Case Report.

Authors:  Zhigao Liu; Shuya Wang; Yu Wang; Aihua Ma; Bojun Zhao
Journal:  Front Med (Lausanne)       Date:  2021-12-24

5.  Macular Hole Formation Following Vitrectomy for Ruptured Retinal Arterial Macroaneurysm.

Authors:  Jae Hong An; Ji Hye Jang
Journal:  Korean J Ophthalmol       Date:  2021-06-04

6.  Autologous Transplantation of the Internal Limiting Membrane for Refractory Macular Hole following Ruptured Retinal Arterial Macroaneurysm: A Case Report.

Authors:  Yumi Iwakawa; Hisanori Imai; Hiromi Kaji; Yuki Mori; Chihiro Ono; Keiko Otsuka; Akiko Miki; Mariko Oishi
Journal:  Case Rep Ophthalmol       Date:  2018-02-01

7.  Delayed closure of macular hole secondary to Terson syndrome after vitrectomy: A case report and literature review.

Authors:  Yan Sheng; Wen Sun; Ye Shen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

8.  Complication associated with intravitreal injection of tissue plasminogen activator for treatment of submacular hemorrhage due to rupture of retinal arterial macroaneurysm.

Authors:  Eiko Tsuiki; Mao Kusano; Takashi Kitaoka
Journal:  Am J Ophthalmol Case Rep       Date:  2019-09-19

9.  Development and spontaneous closure of a secondary macular hole associated with submacular hemorrhage due to polypoidal choroidal vasculopathy: a case report.

Authors:  Minami Chino; Yuji Yoshikawa; Junji Kanno; Takamitsu Nagashima; Yu Sakaki; Takeshi Katsumoto; Masayuki Shibuya; Takuhei Shoji; Jun Makita; Kei Shinoda
Journal:  BMC Ophthalmol       Date:  2020-03-17       Impact factor: 2.209

10.  Spontaneous formation and closure of full thickness macular hole after treatment with anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy.

Authors:  Abhishek Sethia; Jay Sheth; Mahesh Gopalakrishnan; Giridhar Anantharaman
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.